133 related articles for article (PubMed ID: 27537923)
1. Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.
Aldib I; Gelbcke M; Soubhye J; Prévost M; Furtmüller PG; Obinger C; Elfving B; Alard IC; Roos G; Delporte C; Berger G; Dufour D; Zouaoui Boudjeltia K; Nève J; Dufrasne F; Van Antwerpen P
Eur J Med Chem; 2016 Nov; 123():746-762. PubMed ID: 27537923
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors.
Soubhye J; Aldib I; Elfving B; Gelbcke M; Furtmüller PG; Podrecca M; Conotte R; Colet JM; Rousseau A; Reye F; Sarakbi A; Vanhaeverbeek M; Kauffmann JM; Obinger C; Nève J; Prévost M; Zouaoui Boudjeltia K; Dufrasne F; Van Antwerpen P
J Med Chem; 2013 May; 56(10):3943-58. PubMed ID: 23581551
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.
Aldib I; Soubhye J; Zouaoui Boudjeltia K; Vanhaeverbeek M; Rousseau A; Furtmüller PG; Obinger C; Dufrasne F; Nève J; Van Antwerpen P; Prévost M
J Med Chem; 2012 Aug; 55(16):7208-18. PubMed ID: 22793255
[TBL] [Abstract][Full Text] [Related]
4. Characterization of chemical features of potent myeloperoxidase inhibitors.
Soubhye J; Meyer F; Furtmüller P; Obinger C; Dufrasne F; Antwerpen PV
Future Med Chem; 2016 Jul; 8(11):1163-77. PubMed ID: 27402298
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design.
Jantschko W; Furtmüller PG; Zederbauer M; Neugschwandtner K; Lehner I; Jakopitsch C; Arnhold J; Obinger C
Biochem Pharmacol; 2005 Apr; 69(8):1149-57. PubMed ID: 15794935
[TBL] [Abstract][Full Text] [Related]
6. Mapping myeloperoxidase to identify its promiscuity properties using docking and molecular dynamics simulations.
Ramírez-Durán LA; Rosales-Hernández MC; Hernández-Rodríguez M; Mendieta-Wejebe JE; Trujillo-Ferrara J; Correa-Basurto J
Curr Pharm Des; 2013; 19(12):2204-15. PubMed ID: 23016839
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase.
Shaw SA; Vokits BP; Dilger AK; Viet A; Clark CG; Abell LM; Locke GA; Duke G; Kopcho LM; Dongre A; Gao J; Krishnakumar A; Jusuf S; Khan J; Spronk SA; Basso MD; Zhao L; Cantor GH; Onorato JM; Wexler RR; Duclos F; Kick EK
Bioorg Med Chem; 2020 Nov; 28(22):115723. PubMed ID: 33007547
[TBL] [Abstract][Full Text] [Related]
8. Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates.
Forbes LV; Sjögren T; Auchère F; Jenkins DW; Thong B; Laughton D; Hemsley P; Pairaudeau G; Turner R; Eriksson H; Unitt JF; Kettle AJ
J Biol Chem; 2013 Dec; 288(51):36636-47. PubMed ID: 24194519
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
Soubhye J; Chikh Alard I; Aldib I; Prévost M; Gelbcke M; De Carvalho A; Furtmüller PG; Obinger C; Flemmig J; Tadrent S; Meyer F; Rousseau A; Nève J; Mathieu V; Zouaoui Boudjeltia K; Dufrasne F; Van Antwerpen P
J Med Chem; 2017 Aug; 60(15):6563-6586. PubMed ID: 28671460
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors.
Soubhye J; Prévost M; Van Antwerpen P; Zouaoui Boudjeltia K; Rousseau A; Furtmüller PG; Obinger C; Vanhaeverbeek M; Ducobu J; Néve J; Gelbcke M; Dufrasne FO
J Med Chem; 2010 Dec; 53(24):8747-59. PubMed ID: 21090682
[TBL] [Abstract][Full Text] [Related]
11. Rational drug design applied to myeloperoxidase inhibition.
Van Antwerpen P; Zouaoui Boudjeltia K
Free Radic Res; 2015 Jun; 49(6):711-20. PubMed ID: 25788127
[TBL] [Abstract][Full Text] [Related]
12. Methoxyphenol derivatives as reversible inhibitors of myeloperoxidase as potential antiatherosclerotic agents.
Jayaraj P; Narasimhulu CA; Maiseyeu A; Durairaj R; Rao S; Rajagopalan S; Parthasarathy S; Desikan R
Future Med Chem; 2020 Jan; 12(2):95-110. PubMed ID: 31769316
[No Abstract] [Full Text] [Related]
13. Synthetic Guaiacol Derivatives as Promising Myeloperoxidase Inhibitors Targeting Atherosclerotic Cardiovascular Disease.
Premkumar J; Sampath P; Sanjay R; Chandrakala A; Rajagopal D
ChemMedChem; 2020 Jul; 15(13):1187-1199. PubMed ID: 32368837
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the chlorinating activity of myeloperoxidase by tempol: revisiting the kinetics and mechanisms.
Queiroz RF; Vaz SM; Augusto O
Biochem J; 2011 Nov; 439(3):423-31. PubMed ID: 21749327
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry--activity-based protein profiling.
Ward J; Spath SN; Pabst B; Carpino PA; Ruggeri RB; Xing G; Speers AE; Cravatt BF; Ahn K
Biochemistry; 2013 Dec; 52(51):9187-201. PubMed ID: 24320749
[TBL] [Abstract][Full Text] [Related]
17. The soluble curcumin derivative NDS27 inhibits superoxide anion production by neutrophils and acts as substrate and reversible inhibitor of myeloperoxidase.
Franck T; Aldib I; Zouaoui Boudjeltia K; Furtmüller PG; Obinger C; Neven P; Prévost M; Soubhye J; Van Antwerpen P; Mouithys-Mickalad A; Serteyn D
Chem Biol Interact; 2019 Jan; 297():34-43. PubMed ID: 30342014
[TBL] [Abstract][Full Text] [Related]
18. Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO).
Hu CH; Neissel Valente MW; Halpern OS; Jusuf S; Khan JA; Locke GA; Duke GJ; Liu X; Duclos FJ; Wexler RR; Kick EK; Smallheer JM
Bioorg Med Chem Lett; 2021 Jun; 42():128010. PubMed ID: 33811992
[TBL] [Abstract][Full Text] [Related]
19. 4'-Aminochalcones as novel inhibitors of the chlorinating activity of myeloperoxidase.
Zeraik ML; Ximenes VF; Regasini LO; Dutra LA; Silva DH; Fonseca LM; Coelho D; Machado SA; Bolzani VS
Curr Med Chem; 2012; 19(31):5405-13. PubMed ID: 22963624
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid as a substrate and inhibitor of myeloperoxidase: identification of amine adducts and the influence of superoxide dismutase on their formation.
Forbes LV; Furtmüller PG; Khalilova I; Turner R; Obinger C; Kettle AJ
Biochem Pharmacol; 2012 Oct; 84(7):949-60. PubMed ID: 22846601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
